Psoriasis treated with ursodeoxycholic acid: three case reports
- 1 July 2007
- journal article
- case report
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 32 (4), 398-400
- https://doi.org/10.1111/j.1365-2230.2007.02401.x
Abstract
We report three Japanese patients with psoriasis vulgaris associated with nonalcoholic fatty liver disease in which the skin lesions dramatically resolved after treatment of the fatty liver disease with ursodeoxycholic acid (UDCA). According to the literature, arachidonic acid is released from phospholipid by phospholipase A(2) (PLA(2)) and is a precursor of eicosanoids, including prostaglandins, leucotrienes, and thromboxanes, which are potent inflammatory mediators. PLA(2) activity has been reported to be significantly raised in the serum and skin tissue of patients with psoriasis. UDCA has been reported to suppress the increased activity of group IIA PLA(2), a secretory low-molecular-weight PLA(2) (PLA(2)IIA), in HepG2 cells (a human hepatoblastoma-derived cell line) and in gallbladder and gallbladder bile samples from patients with cholesterol stones. Thus, UCDA may improve the skin lesions of patients with psoriasis by suppressing PLA(2)IIA activity.Keywords
This publication has 10 references indexed in Scilit:
- Suppressive effect of ursodeoxycholic acid on type IIA phospholipase A2 expression in HepG2 cellsHepatology, 2005
- Cloning of a Gene for a Novel Epithelium-specific Cytosolic Phospholipase A2, cPLA2δ, Induced in Psoriatic SkinJournal of Biological Chemistry, 2004
- Pathophysiology of psoriasis: coping endotoxins with bile acid therapyPathophysiology, 2003
- CASE REPORT: Combined Treatment with Ursodeoxycholic Acid and Pioglitazone in a Patient with Nash Associated with Type 2 Diabetes and PsoriasisDigestive Diseases and Sciences, 2003
- Use of ursodeoxycholic acid in liver diseasesJournal of Gastroenterology and Hepatology, 2001
- Psoriasis and the arachidonic acid cascadeJournal of Dermatological Science, 1999
- Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆Gastroenterology, 1999
- Taurin-conjugated ursodeoxycholic acid has a reversible inhibitory effect on human keratinocyte growthJournal of Dermatological Science, 1998
- Effects of long-term ursodeoxycholate administration on expression levels of secretory low-molecular-weight phospholipases A and mucin genes in gallbladders and biliary composition in patients with multiple cholesterol stonesHepatology, 1998
- Elevated expression of human nonpancreatic phospholipase A2 in psoriatic tissueInflammation, 1994